Matthias Stelljes
University of Münster(DE)Augenstern(DE)University Hospital Münster(DE)FH Münster(DE)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Hematopoietic Stem Cell Transplantation, Chronic Myeloid Leukemia Treatments, CAR-T cell therapy research
Most-Cited Works
- → Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia(2016)1,340 cited
- → Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival(2011)905 cited
- → Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia(2014)656 cited
- → Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN)(2020)545 cited
- → Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL(2012)466 cited